{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:16:32Z","timestamp":1769526992579,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10549-020-05799-9","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T09:03:53Z","timestamp":1595495033000},"page":"771-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Atypical lobular hyperplasia on core needle biopsy: contemporary results from a large community hospital breast program"],"prefix":"10.1007","volume":"183","author":[{"given":"Dean","family":"Lumley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deidre","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Karwowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Edsall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Francfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Capizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-961X","authenticated-orcid":false,"given":"Johnny","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"issue":"2","key":"5799_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","volume":"7","author":"LC Hartmann","year":"2014","unstructured":"Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL et al (2014) Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res (Phila) 7(2):211\u2013217. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-13-0222","journal-title":"Cancer Prev Res (Phila)"},{"issue":"6","key":"5799_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.7326\/0003-4819-143-6-200509200-00009","volume":"143","author":"G Arpino","year":"2005","unstructured":"Arpino G, Laucirica R, Elledge RM (2005) Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 143(6):446\u2013457","journal-title":"Ann Intern Med"},{"issue":"1","key":"5799_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJMsr1407164","volume":"372","author":"LC Hartmann","year":"2015","unstructured":"Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K (2015) Atypical hyperplasia of the breast\u2014risk assessment and management options. N Engl J Med 372(1):78\u201389. https:\/\/doi.org\/10.1056\/NEJMsr1407164","journal-title":"N Engl J Med"},{"issue":"12","key":"5799_CR4","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/modpathol.2016.127","volume":"29","author":"KL Mooney","year":"2016","unstructured":"Mooney KL, Bassett LW, Apple SK (2016) Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol 29(12):1471\u20131484. https:\/\/doi.org\/10.1038\/modpathol.2016.127","journal-title":"Mod Pathol"},{"issue":"3","key":"5799_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/cam4.223","volume":"3","author":"LP Middleton","year":"2014","unstructured":"Middleton LP, Sneige N, Coyne R, Shen Y, Dong W, Dempsey P et al (2014) Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med 3(3):492\u2013499. https:\/\/doi.org\/10.1002\/cam4.223","journal-title":"Cancer Med"},{"issue":"3","key":"5799_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2214\/AJR.07.2768","volume":"190","author":"RF Brem","year":"2008","unstructured":"Brem RF, Lechner MC, Jackman RJ, Rapelyea JA, Evans WP, Philpotts LE et al (2008) Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol 190(3):637\u2013641. https:\/\/doi.org\/10.2214\/AJR.07.2768","journal-title":"AJR Am J Roentgenol"},{"issue":"13","key":"5799_CR7","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1245\/s10434-012-2538-5","volume":"19","author":"JL Lewis","year":"2012","unstructured":"Lewis JL, Lee DY, Tartter PI (2012) The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Ann Surg Oncol 19(13):4124\u20134128. https:\/\/doi.org\/10.1245\/s10434-012-2538-5","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"5799_CR8","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1245\/s10434-012-2534-9","volume":"19","author":"MG Shah-Khan","year":"2012","unstructured":"Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, Deperi ER, Glazebrook KN (2012) Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia\/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol 19(10):3131\u20133138. https:\/\/doi.org\/10.1245\/s10434-012-2534-9","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"5799_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1309\/AJCPYG48TUTFIBMR","volume":"138","author":"C Zhao","year":"2012","unstructured":"Zhao C, Desouki MM, Florea A, Mohammed K, Li X, Dabbs D (2012) Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol 138(1):72\u201378. https:\/\/doi.org\/10.1309\/AJCPYG48TUTFIBMR","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"5799_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ejso.2011.01.009","volume":"37","author":"M Hussain","year":"2011","unstructured":"Hussain M, Cunnick GH (2011) Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast\u2014a review. Eur J Surg Oncol 37(4):279\u2013289. https:\/\/doi.org\/10.1016\/j.ejso.2011.01.009","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"5799_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2214\/AJR.11.8447","volume":"199","author":"B Niell","year":"2012","unstructured":"Niell B, Specht M, Gerade B, Rafferty E (2012) Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR Am J Roentgenol 199(4):929\u2013935. https:\/\/doi.org\/10.2214\/AJR.11.8447","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"5799_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/cncr.27841","volume":"119","author":"MP Murray","year":"2013","unstructured":"Murray MP, Luedtke C, Liberman L, Nehhozina T, Akram M, Brogi E (2013) Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Cancer 119(5):1073\u20131079. https:\/\/doi.org\/10.1002\/cncr.27841","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05799-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05799-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05799-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T23:58:23Z","timestamp":1626998303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05799-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["5799"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05799-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance of ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Good Samaritan Hospital Medical Center IRB #16-016 approved this minimal risk registry study with waiver of informed consent. There were no vulnerable populations. This study complies with current laws of the United States government for which it was performed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patient consent for publication was obtained via waiver of informed consent. Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}